Breaking News Headlines Today

News from european-biotechnology.com

All of today’s top news stories from European-biotechnology.com. Get the full analysis behind how media bias impacts breaking news.

In total, 75 have been published by European-biotechnology.com which Ground News has aggregated in the past 3 months.

The Ground News media bias check for European-biotechnology.com is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

If you want to know if European-biotechnology.com is credible or reliable, look no further. We rank European-biotechnology.com as Unknown factuality. Find out more about our methodology here.

Information about European-biotechnology.com

Where is European-biotechnology.com located?European-biotechnology.com's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Sarepta’s Future in Gene Therapy Remains Clouded, But Data From Partner Hansa Is a Bright Spot

100% Center coverage: 1 sources

Hansa Biopharma has encouraging early clinical results showing its drug imlifidase, used as a pretreatment, enabled Duchenne muscular dystrophy patients to receive the gene therapy Elevidys. Sarepta is searching for ways to mitigate excessive immune responses to Elevidys that can lead to serious and potentially fatal liver injury.See the Story

EMBL and BIS: Advancing Biological Imaging - European Biotechnology Magazine

The EMBL Imaging Centre has received €7 million in support from Boehringer Ingelheim Stiftung to further advance its cutting-edge imaging technologies. The post EMBL and BIS: Advancing Biological Imaging appeared first on European Biotechnology Magazine.Heidelberg, Germany · Heidelberg Read Article

LIfT BioSciences Ltd receives €12m for clinical translation of IMANs - European Biotechnology Magazine

LIfT BioSciences Ltd, active in London, Galway and Houston, has been awarded a grant of €12m from the Disruptive Technologies Innovation Fund (DTIF) to support the clinical translation of its Immuno-Modulatory Alpha Neutrophils (IMANs). This funding will enable the preparation of the world’s first allogeneic therapy using synthetically programmed neutrophil granulocytes for Phase I trials. The post LIfT BioSciences Ltd receives €12m for clinical…London, England · London Read Article

News from european-biotechnology.com

News from european-biotechnology.com

Information about European-biotechnology.com

Media Bias Ratings

Factuality

Ownership

Top European-biotechnology.com News

Trump demands pharma companies slash drug prices in next 60 days

Bayer Buys Into KRAS with $1.3bn Kumquat Deal

IO Bio Plans Cancer Vaccine Filing Despite Trial Miss

Experienced immunologist as CMO - European Biotechnology Magazine

New managing director takes over - European Biotechnology Magazine

Dewpoint Therapeutics, biotech startup in a once-buzzy field, cuts 70% of staff

EU Biotech Act: Have your say! - European Biotechnology Magazine

ReiThera starts study on HIV vaccine - European Biotechnology Magazine

Sarepta’s Future in Gene Therapy Remains Clouded, But Data From Partner Hansa Is a Bright Spot

EMBL and BIS: Advancing Biological Imaging - European Biotechnology Magazine

LIfT BioSciences Ltd receives €12m for clinical translation of IMANs - European Biotechnology Magazine

Similar News Topics

Topics Most Covered by european-biotechnology.com

Sources Covering Similar Topics

Breaking News Topics Related to European-biotechnology.com

Information about European-biotechnology.com

Media Bias Ratings

Factuality

Ownership

Experienced immunologist as CMO - European Biotechnology Magazine

New managing director takes over - European Biotechnology Magazine

Dewpoint Therapeutics, biotech startup in a once-buzzy field, cuts 70% of staff

EU Biotech Act: Have your say! - European Biotechnology Magazine

ReiThera starts study on HIV vaccine - European Biotechnology Magazine

Sarepta’s Future in Gene Therapy Remains Clouded, But Data From Partner Hansa Is a Bright Spot

EMBL and BIS: Advancing Biological Imaging - European Biotechnology Magazine

LIfT BioSciences Ltd receives €12m for clinical translation of IMANs - European Biotechnology Magazine